Dextromethorphan Distribution Act of 2009

Bill 111 hr 1259, also known as the Dextromethorphan Distribution Act of 2009, was introduced in the US Congress with the aim of regulating the distribution of dextromethorphan, a common ingredient found in over-the-counter cough medicines. The bill sought to address concerns about the misuse and abuse of dextromethorphan, particularly among teenagers and young adults.

The key provisions of the bill included requiring retailers to verify the age of individuals purchasing products containing dextromethorphan, as well as limiting the quantity of these products that could be sold to an individual in a single transaction. The bill also called for increased education and awareness campaigns about the dangers of dextromethorphan abuse, as well as enhanced penalties for those who illegally distribute or sell the substance.

Supporters of the bill argued that these measures were necessary to combat the growing problem of dextromethorphan abuse, which had been linked to a number of negative health outcomes, including addiction and overdose. However, opponents raised concerns about the potential impact of the bill on legitimate users of dextromethorphan-containing products, as well as the feasibility of enforcing the proposed regulations. Ultimately, the Dextromethorphan Distribution Act of 2009 did not pass into law, and the regulation of dextromethorphan remains a topic of ongoing debate and discussion in the US Congress.